PDF(980 KB)
Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children
GUO Jing-Min, SHI Xiao-Xi, YANG Shi-Wei, QIAN Qin-Fang, HUANG Yan, XIE Yan-Qin, OU Ping
Chinese Journal of Contemporary Pediatrics ›› 2017, Vol. 19 ›› Issue (7) : 786-789.
PDF(980 KB)
PDF(980 KB)
Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children
Objective To investigate the difference in the efficacy between clonidine transdermal patch and haloperidol tablets in the treatment of moderate to severe tic disorders in children. Methods A total of 134 children with moderate to severe tic disorders were randomly divided into clonidine group (n=70) and haloperidol group (n=64). The clonidine and haloperidol groups were treated with clonidine transdermal patch and haloperidol tablets respectively, and the treatment lasted for 8 weeks in both groups. The Yale Global Tic Severity Scale (YGTSS) was used to evaluate the conditions of the children before and after treatment, and the adverse events during the treatment were recorded. Results The haloperidol group had a signifcantly better treatment outcome than the clonidine group after one week of treatment (P < 0.05); the treatment outcome showed no signifcant difference between the two groups after 3, 5, and 8 weeks of treatment (P > 0.05). The clonidine group had signifcantly less reductions in the motor tics, vocal tics, and function impairment scores and total score of YGTSS than the haloperidol group after one week of treatment (P < 0.05); there were no signifcant differences in YGTSS score reductions between the two groups after 3, 5, and 8 weeks of treatment (P > 0.05). The clonidine group had a signifcantly lower overall incidence of adverse events than the haloperidol group (8% vs 37%; P < 0.01). Conclusions Clonidine transdermal patch and haloperidol are both effective in the treatment of moderate to severe tic disorders in children. The clonidine transdermal patch, despite slow action, has comparable effcacy and fewer adverse effects compared with haloperidol.
Clonidine transdermal patch / Tic disorder / Effcacy / Child
[1] 唐渊, 江莲英, 陈若珊, 等. 218例儿童抽动障碍临床分析及误诊原因探讨[J]. 中国妇幼保健, 2010, 25(17):2371-2373.
[2] 刘艳艳, 陈燕惠, 陈辉, 等. 阿立哌唑与泰必利治疗儿童抽动障碍的对照研究[J]. 中国当代儿科杂志, 2010, 12(6):421-424.
[3] Du YS, Li HF, Vance A, et al. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders[J]. Aust N Z J Psychiatry, 2008, 42(9):807-813.
[4] 王健彪, 徐晓华, 华颖. 可乐定透皮贴剂治疗58例儿童Tourette综合征的临床研究[J]. 中国儿童保健杂志, 2016, 24(9):1002-1005.
[5] Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders:pharmacotherapy[J]. Can J Psychiatry, 2012, 57(3):133-143.
[6] Roessner V, Plessen KJ, Rothenberger A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part Ⅱ:pharmacological treatment[J]. Eur Child Adolesc Psychiatry, 2011, 20(4):173-196.
[7] 柯钟灵, 陈燕惠, 念欲霞, 等. 可乐定透皮贴治疗儿童抽动障碍疗效与安全性的系统评价和Meta分析[J]. 中国循证儿科杂志, 2016, 11(6):426-430.
[8] 康华, 张月芳, 焦富勇, 等. 可乐定透皮贴剂治疗儿童抽动-秽语综合征的疗效观察[J]. 中国当代儿科杂志, 2009, 11(7):537-539.
[9] Jiao F, Zhang X, Zhang X, et al. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch[J]. Eur J Paediatr Neurol, 2016, 20(1):80-84.
[10] 中华医学会精神病学分会. 中国精神障碍分类与诊断标准第三版(精神障碍分类)[J]. 中华精神科杂志, 2001, 34(3):184-188.
[11] 衣明纪, 马遥, 刘秀梅, 等. 儿童抽动障碍的诊断与评估:单中心10年回顾性研究[J]. 中华诊断学电子杂志, 2013, 1(1):25-31.
[12] 郑喜英, 刘芳, 程志忠, 等. 托吡酯联合心理干预治疗儿童抽动症疗效分析[J]. 中国实用神经疾病杂志, 2014, 17(20):111.
[13] 吕娟. 可乐定透皮贴片和盐酸硫必利治疗抽动障碍的对比研究[D]. 吉林:吉林大学, 2015.
[14] 纪小艺, 吴敏. 抽动障碍患儿治疗前后多巴胺D2受体与转运体mRNA的表达[J]. 中国当代儿科杂志, 2016, 18(4):297-300.
[15] 周亚兵, 吴敏, 阎秀菊, 等. 祛风止动方对抽动障碍小鼠神经行为学与Notch1、D2RmRNA表达的影响[J]. 中国中西医结合杂志, 2009, 29(6):519-523.
[16] 胡敏, 颜刚. 可乐定缓释片治疗抽动症的疗效及不良反应的初步研究[J]. 中国儿童保健杂志, 2014, 22(12):1326-1327.
[17] 刘平, 吴惧, 周文智, 等. 可乐定治疗共患注意缺陷多动障碍的抽动障碍患儿的临床疗效[J]. 儿科药学杂志, 2012, 18(6):18-21.
[18] 钟佑泉, 周文智, 胡文广, 等. 可乐定透皮贴剂治疗儿童抽动障碍的随机双盲对照研究[J]. 中华儿科杂志, 2007, 45(10):785-787.
[19] Stevens JR, Justin Coffey M, Fojtik M, et al. The use of transdermal therapeutic systems in psychiatric care:A primer on patches[J]. Psychosomatics, 2015, 56(5):423-444.
[20] 杜亚松, 李华芳, 钟佑泉, 等. 可乐定透皮贴剂治疗抽动障碍的随机、双盲、安慰剂对照、多中心临床试验[J]. 上海精神医学, 2006, 18(4):193-198.
[21] 高超, 吴永利, 刘君婷, 等. 氟哌啶醇联合可乐定透皮贴剂治疗儿童难治性Tourette综合征及对Th1/Th2的影响[J]. 疑难病杂志, 2016, 15(12):1259-1262.
